OR WAIT 15 SECS
Melanie Sena is community editor of Pharmaceutical Technology.
ChemCon passes its fourth FDA inspection in the 17-year history of the company.
ChemCon, a Freiburg, Germany-based contract research company that offers custom synthesis of APIs and fine chemicals, has announced that it successfully passed an FDA inspection.
The March 2014 inspection for GMP compliance was the fourth in the 17-year history of the company. The inspection examined all quality assurance systems of the company relating to production, equipment,manufacturing facilities, materials, and quality controls. No form 483 was issued, the quality systems were considered acceptable, and the inspection was classified as no action indicated, the company reports.